The role of carbonic anhydrases IX and XII in hypoxia-driven tumor adaptation and chemoresistance: an underexplored frontier for novel therapeutic strategies in ovarian cancer
- 1Department of Infectomics and Molecular Pathogenesis. Center for Research and Advanced Studies, CDMX, México
- 2Faculty of Chemical Sciences, Autonomous University of Chihuahua, Chihuahua, Mexico
- 3Institute of Biostructures and Bioimaging (CNR), Naples, Italy
Abstract
Human carbonic anhydrases IX and XII (hCA IX/XII) regulate pH homeostasis and may facilitate tumor adaptation, progression, and therapeutic resistance. Although extensively studied in other malignancies, their roles in ovarian cancer (OC) remain insufficiently characterized. This narrative review critically examines their biological functions and therapeutic potential, emphasizing hypoxia and acidosis within the heterogeneous ovarian tumor microenvironment. Literature was searched in PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar, prioritizing studies on hypoxia, acidosis, chemoresistance, and carbonic anhydrase inhibition. Evidence from OC models was distinguished from findings in other cancers. Public transcriptomic data were additionally explored using GEPIA and Kaplan–Meier Plotter to examine CA9 and CA12 expression and survival associations. Available findings suggest potential roles for these isoenzymes in adaptation to acidic, hypoxic conditions, but OC-specific mechanistic and therapeutic evidence remains limited. We discuss preclinical inhibitors, key knowledge gaps, and priorities for future research.
Related
- From biofilm tolerance to antimicrobial resistance: molecular adaptation strategies and emerging therapeutic vulnerabilities in resistant pathogens
- Carbon Capture and Utilization Through Microalgae and Carbonic Anhydrases: Opportunities, Challenges and Future Directions
- Editorial: The role of RNA regulation in cancer pathogenesis and therapeutic strategies
- Epigenetic plasticity in cancer drug resistance: mechanistic insights and strategies for therapeutic intervention
- Biochemical Characteristics of the Vascular Microenvironment in Pathological Conditions and Precision Therapeutic Strategies
BibTeX
@article{calderon2026role,
title = {{The role of carbonic anhydrases IX and XII in hypoxia-driven tumor adaptation and chemoresistance: an underexplored frontier for novel therapeutic strategies in ovarian cancer}},
author = {Alejandro Velarde Calderón and José Jesús Guzmán Mendoza and Blanca Sánchez-Ramírez and Giuseppina De Simone and Patricia Talamás-Rohana},
journal = {Cancer Biology \& Therapy},
year = {2026},
month = nov,
doi = {10.1080/15384047.2026.2757322},
url = {https://doi.org/10.1080/15384047.2026.2757322},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - The role of carbonic anhydrases IX and XII in hypoxia-driven tumor adaptation and chemoresistance: an underexplored frontier for novel therapeutic strategies in ovarian cancer
AU - Alejandro Velarde Calderón
AU - José Jesús Guzmán Mendoza
AU - Blanca Sánchez-Ramírez
AU - Giuseppina De Simone
AU - Patricia Talamás-Rohana
PY - 2026
DA - 2026/11/08
JO - Cancer Biology & Therapy
DO - 10.1080/15384047.2026.2757322
UR - https://doi.org/10.1080/15384047.2026.2757322
AB - Human carbonic anhydrases IX and XII (hCA IX/XII) regulate pH homeostasis and may facilitate tumor adaptation, progression, and therapeutic resistance. Although extensively studied in other malignancies, their roles in ovarian cancer (OC) remain insufficiently characterized. This narrative review critically examines their biological functions and therapeutic potential, emphasizing hypoxia and acidosis within the heterogeneous ovarian tumor microenvironment. Literature was searched in PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar, prioritizing studies on hypoxia, acidosis, chemoresistance, and carbonic anhydrase inhibition. Evidence from OC models was distinguished from findings in other cancers. Public transcriptomic data were additionally explored using GEPIA and Kaplan–Meier Plotter to examine CA9 and CA12 expression and survival associations. Available findings suggest potential roles for these isoenzymes in adaptation to acidic, hypoxic conditions, but OC-specific mechanistic and therapeutic evidence remains limited. We discuss preclinical inhibitors, key knowledge gaps, and priorities for future research.
SN - 1538-4047
SN - 1555-8576
ER -